Upregulation of Hic-5 in glomerulosclerosis and its regulation of mesangial cell apoptosis

Kidney International

Volumn 77, Issue 4, 2010, Pages 329-338

  Hornigold, Nick ^a   Craven, Rachel A ^a   Keen, Jeff N ^b   Johnson, Tim ^c   Banks, Rosamonde E ^a   Mooney, Andrew F ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cell survival; Cell matrix interactions; Extracellular matrix; Glomerulosclerosis; Mesangial cells

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; HYDROGEN PEROXIDE INDUCED CLONE 5; NUCLEIC ACID BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL LYSATE; CELL PROTECTION; CONTROLLED STUDY; GLOMERULOSCLEROSIS; MALE; MESANGIUM; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEOMICS; RAT; UPREGULATION;

EID: 75749130217     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.417     Document Type: Article

References (57)

1. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl 2005: S7-S10. (Pubitemid 43307841)
2. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217. (Pubitemid 43323069)
3. Sugiyama H, Kashihara N, Makino H et al. Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103-111.
4. Baker AJ, Mooney A, Hughes J et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994; 94: 2105-2116.
5. Couchman JR, Beavan LA, McCarthy KJ. Glomerular matrix: synthesis, turnover and role in mesangial expansion. Kidney Int 1994; 45: 328-335.
6. Gilmore AP. Anoikis. Cell Death Differ 2005; 12(Suppl 2): 1473-1477.
7. Mooney A, Jackson K, Bacon R et al. Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals. Am J Pathol 1999; 155: 599-606.
8. Mooney A, Jobson T, Bacon R et al. Cytokines promote glomerular mesangial cell survival in vitro by stimulus-dependent inhibition of apoptosis. J Immunol 1997; 159: 3949-3960.
9. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-687.
10. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70: 389-399.
11. Parsons JT, Schaller MD, Hildebrand J et al. Focal adhesion kinase: structure and signalling. J Cell Sci Suppl 1994; 18: 109-113.
12. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116: 1409-1416.
13. Giancotti FG. Complexity and specificity of integrin signalling. Nat Cell Biol 2000; 2: E13-E14.
14. Wary KK, Mainiero F, Isakoff SJ et al. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 1996; 87: 733-743.
15. Lo SH, Weisberg E, Chen LB. Tensin: a potential link between the cytoskeleton and signal transduction. Bioessays 1994; 16: 817-823.
16. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 2003; 19: 173-206.
17. Gilmore AP, Metcalfe AD, Romer LH et al. Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol 2000; 149: 431-446.
18. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626.
19. Pullan S, Wilson J, Metcalfe A et al. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci 1996; 109(Part 3): 631-642.
20. Boudreau N, Sympson CJ, Werb Z et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-893.
21. Zhang J, Zhang LX, Meltzer PS et al. Molecular cloning of human Hic-5, a potential regulator involved in signal transduction and cellular senescence. Mol Carcinog 2000; 27: 177-183.
22. Thomas GL, Yang B, Wagner BE et al. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 1998; 13: 2216-2226.
23. Nishiya N, Shirai T, Suzuki W et al. Hic-5 interacts with GIT1 with a different binding mode from paxillin. J Biochem 2002; 132: 279-289.
24. Lazebnik YA, Kaufmann SH, Desnoyers S et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346-347.
25. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
26. Ahmed AK, Haylor JL, El Nahas AM et al. Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int 2007; 71: 755-763.
27. Johnson TS, Fisher M, Haylor JL et al. Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J Am Soc Nephrol 2007; 18: 3078-3088.
28. Runyon ST, Zhang Y, Appleton BA et al. Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3. Protein Sci 2007; 16: 2454-2471. (Pubitemid 350036751)
29. Oka C, Tsujimoto R, Kajikawa M et al. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 2004; 131: 1041-1053.
30. Murwantoko, Yano M, Ueta Y et al. Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. Biochem J 2004; 381: 895-904.
31. Krynetskaia N, Xie H, Vucetic S et al. High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs. Mol Pharmacol 2008; 73: 260-269.
32. Chung HJ, Liu J, Dundr M et al. FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol 2006; 26: 6584-6597.
33. Hu Y, Cascone PJ, Cheng L et al. Lepidopteran DALP, and its mammalian ortholog HIC-5, function as negative regulators of muscle differentiation. Proc Natl Acad Sci USA 1999; 96: 10218-10223.
34. Thomas SM, Hagel M, Turner CE. Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. J Cell Sci 1999; 112(Part 2): 181-190.
35. Guerrero-Santoro J, Yang L, Stallcup MR et al. Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation. J Cell Biochem 2004; 92: 810-819.
36. Shibanuma M, Kim-Kaneyama JR, Sato S et al. A LIM protein, Hic-5, functions as a potential coactivator for Sp1. J Cell Biochem 2004; 91: 633-645.
37. Jia Y, Ransom RF, Shibanuma M et al. Identification and characterization of hic-5/ARA55 as an hsp27 binding protein. J Biol Chem 2001; 276: 39911-39918.
38. Wang H, Song K, Sponseller TL et al. Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling. J Biol Chem 2005; 280: 5154-5162.
39. Nishiya N, Tachibana K, Shibanuma M et al. Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase. Mol Cell Biol 2001; 21: 5332-5345.
40. Shibanuma M, Kim-Kaneyama JR, Ishino K et al. Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol Biol Cell 2003; 14: 1158-1171.
41. Kim-Kaneyama J, Shibanuma M, Nose K. Transcriptional activation of the c-fos gene by a LIM protein, Hic-5. Biochem Biophys Res Commun 2002; 299: 360-365.
42. Panetti TS, Hannah DF, Avraamides C et al. Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid. J Thromb Haemost 2004; 2: 1645-1656.
43. Yuminamochi T, Yatomi Y, Osada M et al. Expression of the LIM proteins paxillin and Hic-5 in human tissues. J Histochem Cytochem 2003; 51: 513-521.
44. Shibanuma M, Iwabuchi Y, Nose K. Possible involvement of hic-5, a focal adhesion protein, in the differentiation of C2C12 myoblasts. Cell Struct Funct 2002; 27: 21-27.
45. Ishino K, Kaneyama, Shibanuma M et al. Specific decrease in the level of Hic-5, a focal adhesion protein, during immortalization of mouse embryonic fibroblasts, and its association with focal adhesion kinase. J Cell Biochem 2000; 76: 411-419.
46. Kim-Kaneyama JR, Wachi N, Sata M et al. Hic-5, an adaptor protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. Biochem Biophys Res Commun 2008; 376: 682-687.
47. Sheibani N, Tang Y, Sorenson CM. Paxillin's LD4 motif interacts with bcl-2. J Cell Physiol 2008; 214: 655-661.
48. Sorenson CM. Interaction of bcl-2 with paxillin through its BH4 domain is important during ureteric bud branching. J Biol Chem 2004; 279: 11368-11374.
49. Pichler RH, Bassuk JA, Hugo C et al. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro. Am J Pathol 1996; 148: 1153-1167.
50. Johnson RJ, Raines EW, Floege J et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992; 175: 1413-1416.
51. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364.
52. Border WA, Okuda S, Languino LR et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371-374.
53. Kitamura M, Kawachi H. Creation of an in vivo cytosensor using engineered mesangial cells. Automatic sensing of glomerular inflammation controls transgene activity. J Clin Invest 1997; 100: 1394-1399.
54. Yokoo T, Kitamura M. IL-1beta depresses expression of the 70-kilodalton heat shock protein and sensitizes glomerular cells to oxidant-initiated apoptosis. J Immunol 1997; 159: 2886-2892.
55. Lovett DH, Sterzel RB. Cell culture approaches to the analysis of glomerular inflammation. Kidney Int 1986; 30: 246-254.
56. Yan JX, Wait R, Berkelman T et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000; 21: 3666-3672.
57. Tomlinson DC, Hurst CD, Knowles MA. Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer. Oncogene 2007; 26: 5889-5899.